Sonova United States Hearing Instruments LLC
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Sonova United States Hearing Instruments LLC
Live alerts from global media, monitored by Business Radar
2025-02-06 (jomfruland.net)
Sonova Holding: Why high roe of this stock may not signal growth -
Son's holding has a strong return on its own capital (ROE) of 25 %, which exceeds the average of 12 %. The company has seen a slight profit growth of 4.2 % in the last five years, which significantly lags behind the growth rate of the 11 % industry. Medini's payment ratio of SONOVA payments of 43 % suggests a balanced approach between paying dividends and reinvestics into growth. Analysts predict a future ROE of 27 %, which arises as to its correlation with profit growth. Investors should monitor Son's strategies for capital allocation and growth to assess its long -term potential. Sonova holding shares can be the last
Read more
2025-01-15 (agefi.com)
Sonova confirms its forecasts for the 2024/25 financial year | .com
The hearing aid manufacturer is benefiting from strong demand for its new Phonak platforms and expects revenue growth of 6-9% and an adjusted Ebita of 7-11%.
Read more
2024-11-28 (altroconsumo.it)
Hearing aids put to the test by data
Sonova (304.6 Swiss francs; Isin CH0012549785) achieved mixed results in the first half of 2024/25 (the fiscal year ends at the end of March). While turnover, up by 5.9%, benefited from the good performance of sales of hearing aids and cochlear implants, industrial profit fell by 4.9%, penalized by restructuring costs and the costs of launching a new appliance. Even if the tightening of competition (even Apple has entered the hearing health sector) weighs on margins, it should still be able to maintain technological leadership. In August it launched an AI-powered hearing platform that drew positive reactions from customers. Confirms the forecasts for turnover (+6/9%) and industrial profit (+7/11%) for the whole of 2024/25. The only flaw is that the strong Swiss franc risks cutting revenue growth by 1-2% and industrial profit growth by 4-5%.
Read more
2024-11-19 (marketscreener.com)
Launch costs hit Sonova's profit, as it bets on new product with AI tech
Sonova reported half-year core profit below market expectations on Tuesday, hit by costs related to the launch of its new AI-boosted hearing device which it is betting on to regain market share. ...
Read more
2024-09-30 (fyens.dk)
The profit increases: Sonova Denmark A/S got a million plus
The profit has increased in the past year in the Middelfart company Sonova Denmark A/S. This appears from the latest accounts for 2023/24, which the company has just registered with the Danish Business Authority.
Read more
2024-08-17 (forex.ca)
Eargo Seeks To Reignite Revenue Growth After Major Stumble (NASDAQ:EAR)
peakSTOCK Eargo, Inc. (NASDAQ:EAR) went public on October 15, 2020, raising approximately $141 million in gross proceeds in an IPO that was priced at $18.
Read more
2024-01-31 (euroinvestor.dk)
The stock has exploded - that's what the analysts now expect
The share in the large Danish hearing aid company Demant has risen by as much as 62.8 per cent. during the last 12 months.
Read more
2023-11-21 (nzz.ch)
Sonova: The hearing aid manufacturer's shares are taking off despite a profit warning
The hearing aid giant had gone on the defensive and lost market share. Now growth comes before profitability. Customers must be won back.
Read more
2023-11-21 (tvsvizzera.it)
Sonova, figures decreasing in the first half of the year
The first half of the 2023/24 financial year was downbeat for Sonova, which saw both revenues and profitability decline. The group active worldwide in the manufacturing of hearing aids has in fact closed the period under review, for which it considers the months from April to September, with a
Read more